610 related articles for article (PubMed ID: 23487023)
1. NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17).
Romee R; Foley B; Lenvik T; Wang Y; Zhang B; Ankarlo D; Luo X; Cooley S; Verneris M; Walcheck B; Miller J
Blood; 2013 May; 121(18):3599-608. PubMed ID: 23487023
[TBL] [Abstract][Full Text] [Related]
2. Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition.
Wiernik A; Foley B; Zhang B; Verneris MR; Warlick E; Gleason MK; Ross JA; Luo X; Weisdorf DJ; Walcheck B; Vallera DA; Miller JS
Clin Cancer Res; 2013 Jul; 19(14):3844-55. PubMed ID: 23690482
[TBL] [Abstract][Full Text] [Related]
3. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
[TBL] [Abstract][Full Text] [Related]
4. ADAM17-mediated shedding of FcγRIIIA on human NK cells: identification of the cleavage site and relationship with activation.
Lajoie L; Congy-Jolivet N; Bolzec A; Gouilleux-Gruart V; Sicard E; Sung HC; Peiretti F; Moreau T; Vié H; Clémenceau B; Thibault G
J Immunol; 2014 Jan; 192(2):741-51. PubMed ID: 24337742
[TBL] [Abstract][Full Text] [Related]
5. Glycodelin-A stimulates the conversion of human peripheral blood CD16-CD56bright NK cell to a decidual NK cell-like phenotype.
Lee CL; Vijayan M; Wang X; Lam KKW; Koistinen H; Seppala M; Li RHW; Ng EHY; Yeung WSB; Chiu PCN
Hum Reprod; 2019 Apr; 34(4):689-701. PubMed ID: 30597092
[TBL] [Abstract][Full Text] [Related]
6. Identification of an ADAM17 cleavage region in human CD16 (FcγRIII) and the engineering of a non-cleavable version of the receptor in NK cells.
Jing Y; Ni Z; Wu J; Higgins L; Markowski TW; Kaufman DS; Walcheck B
PLoS One; 2015; 10(3):e0121788. PubMed ID: 25816339
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of ADAM17 in cord blood stem cell-derived CD16
Valipour B; Mohammadi SM; Abedelahi A; Charoudeh HN
Hum Immunol; 2024 May; 85(3):110769. PubMed ID: 38429146
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
[TBL] [Abstract][Full Text] [Related]
9. Cytokine secretion and NK cell activity in human ADAM17 deficiency.
Tsukerman P; Eisenstein EM; Chavkin M; Schmiedel D; Wong E; Werner M; Yaacov B; Averbuch D; Molho-Pessach V; Stepensky P; Kaynan N; Bar-On Y; Seidel E; Yamin R; Sagi I; Elpeleg O; Mandelboim O
Oncotarget; 2015 Dec; 6(42):44151-60. PubMed ID: 26683521
[TBL] [Abstract][Full Text] [Related]
10. Membrane-type 6 matrix metalloproteinase regulates the activation-induced downmodulation of CD16 in human primary NK cells.
Peruzzi G; Femnou L; Gil-Krzewska A; Borrego F; Weck J; Krzewski K; Coligan JE
J Immunol; 2013 Aug; 191(4):1883-94. PubMed ID: 23851692
[TBL] [Abstract][Full Text] [Related]
11. CD56
Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Fc gamma receptor IIIA alpha (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C.
Borrego F; Lopez-Beltran A; Peña J; Solana R
Cell Immunol; 1994 Oct; 158(1):208-17. PubMed ID: 8087866
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency of ILT2-expressing CD56(dim)CD16(+) NK cells correlates with disease severity of pulmonary tuberculosis.
Wang X; Meng X; Zheng Y; Jiang J; Yang B; Liu Y; Zhai F; Cheng X
Tuberculosis (Edinb); 2014 Sep; 94(5):469-74. PubMed ID: 24909369
[TBL] [Abstract][Full Text] [Related]
14. IL-12 directs further maturation of ex vivo differentiated NK cells with improved therapeutic potential.
Lehmann D; Spanholtz J; Sturtzel C; Tordoir M; Schlechta B; Groenewegen D; Hofer E
PLoS One; 2014; 9(1):e87131. PubMed ID: 24498025
[TBL] [Abstract][Full Text] [Related]
15. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding.
Aramburu J; Azzoni L; Rao A; Perussia B
J Exp Med; 1995 Sep; 182(3):801-10. PubMed ID: 7650486
[TBL] [Abstract][Full Text] [Related]
16. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
17. CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells.
Márquez ME; Millet C; Stekman H; Conesa A; Deglesne PA; Toro F; Sanctis JD; Blanca I
Cell Immunol; 2010; 264(1):86-92. PubMed ID: 20553754
[TBL] [Abstract][Full Text] [Related]
18. Regulatory role of membrane-bound form interleukin-15 on human uterine microvascular endothelial cells in circulating CD16(-) natural killer cell extravasation into human endometrium.
Kitaya K; Yasuo T
Biol Reprod; 2013 Sep; 89(3):70. PubMed ID: 23904514
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy.
Zhou Q; Gil-Krzewska A; Peruzzi G; Borrego F
Clin Exp Immunol; 2013 Jul; 173(1):131-9. PubMed ID: 23607800
[TBL] [Abstract][Full Text] [Related]
20. Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation.
Mishra HK; Dixon KJ; Pore N; Felices M; Miller JS; Walcheck B
Front Immunol; 2021; 12():711621. PubMed ID: 34367174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]